U.S. Pharmacist



Vitamin B12 May Protect Against Alzheimer's Disease

By Staff


US Pharm. 2010;35(11):8. 

Stockholm, Sweden—New research published in Neurology indicates that vitamin B12 may reduce the risk of Alzheimer's disease (AD). In a 7-year study led by Babak Hooshmand, MD, of the Karolinska Institute, periodic blood samples were taken from 271 elderly subjects without AD at baseline and tested for homocysteine and holotranscobalamin, the active portion of the vitamin. Vitamin B12 can lower homocysteine, which has been linked to a risk of AD. Subjects with the highest B12 levels were least likely to develop AD. Each micromolar increase in homocysteine concentration increased risk of AD by 16%, whereas each picomolar increase in holotranscobalamin reduced risk by 2%. “More research is needed…before vitamin B12 should be used solely as a supplement to help protect memory,” said Dr. Hooshmand. 

To comment on this article, contact rdavidson@uspharmacist.com.

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2016 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.